NCT06821503 2026-03-10
Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Bristol-Myers Squibb
Abbisko Therapeutics Co, Ltd
Shouyao Holdings (Beijing) Co. LTD
The Affiliated Hospital of Xuzhou Medical University
Immodulon Therapeutics Ltd
Chinese PLA General Hospital